Benign Prostate Hypertrophy(BPH)

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

BALT
BALTCA - Irvine
1 program
Liquid embolic agentN/A1 trial
Active Trials
NCT07255508Not Yet RecruitingEst. Nov 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
BALTLiquid embolic agent

Clinical Trials (1)

NCT07255508BALTLiquid embolic agent

Efficacy of Prostatic Arteries Embolization Using SQUIDPERI

Start: Nov 2025Est. completion: Nov 2027
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space